228 results
424B3
CRVO
CervoMed Inc
6 Jun 24
Prospectus supplement
6:03am
. The majority of survivors of an acute stroke demonstrate some level of neurological recovery during the three to six months after the initial event … and claims involving health care items or services reimbursed by nongovernmental third-party payors, including private insurers.
The majority of states also
8-K
EX-10.1
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
to the merger or consolidation are immediately after such merger or consolidation the direct or indirect beneficial owners of a majority of the voting … by a vote of at least a majority of the directors then still in office who either were directors at the beginning of the 12-month period or whose election
8-K
EX-10.1
fe9a ltexl
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K
EX-4.2
cs5r6l
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K
EX-10.3
mzz2m
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
7n71 5rhbvo2ito
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.2
o0ihvep0y6 cf
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
51bc1fmvh7utp2q752zx
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
8-K/A
EX-99.2
ksw7uj3mrow39rxg8
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.3
p48uxau0s1c1rybc twm
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
EX-3.5
n7rada6 hl0o6v3v
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
nwhsei
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
425
EX-99.2
5dy8kmm
9 Aug 23
Business combination disclosure
4:02pm